Correlation Between DexCom and Vivos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Vivos Therapeutics, you can compare the effects of market volatilities on DexCom and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Vivos Therapeutics.

Diversification Opportunities for DexCom and Vivos Therapeutics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between DexCom and Vivos is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of DexCom i.e., DexCom and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between DexCom and Vivos Therapeutics

Given the investment horizon of 90 days DexCom Inc is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, DexCom Inc is 12.95 times less risky than Vivos Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,005  in Vivos Therapeutics on September 20, 2024 and sell it today you would lose (515.00) from holding Vivos Therapeutics or give up 51.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Vivos Therapeutics

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Vivos Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

DexCom and Vivos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Vivos Therapeutics

The main advantage of trading using opposite DexCom and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.
The idea behind DexCom Inc and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities